文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

ARDS患者当前与演进中的诊疗标准

Current and evolving standards of care for patients with ARDS.
PubMed 文献 · Intensive Care Med · 2020-11-06
一句话结论ARDS诊疗标准分当前标准(小潮气量、限制气道压、标准PEEP、中重度俯卧位、VV-ECL S、COVID-19激素、非休克保守液体)与演进标准(驱动压/机械功限制、个体化PEEP、清醒俯卧位监测、非COVID激素、生物制剂)。

本叙述性综述回顾ARDS描述50年来诊疗标准的变迁,将标准分为当前标准(证据确凿、已作为常规治疗目标)与演进标准(有前景、可能未来广泛采用)。当前标准涵盖三领域:通气管理(限制潮气量和气道压、标准PEEP设置)、通气辅助(中重度ARDS俯卧位、严重低氧或通气困难者俯卧位后VV-ECLS)、药物治疗(COVID-19相关ARDS使用皮质激素、非休克患者保守液体策略)。演进标准可能包括限制驱动压或机械功、个体化PEEP滴定、自主呼吸期间监测、非COVID-19 ARDS激素及针对特定亚表型的生物制剂。综述未提供具体数值阈值或剂量。

要点

  • 当前标准:ARDS通气管理应限制潮气量和气道压,并按标准方法设置PEEP。
  • 当前标准:中重度ARDS应使用俯卧位通气。
  • 当前标准:严重低氧血症或通气困难患者,俯卧位后考虑VV-ECLS。
  • 当前标准:COVID-19相关ARDS使用皮质激素;非休克患者采用保守液体策略。
  • 演进标准:可能聚焦限制驱动压或机械功、个体化PEEP滴定、自主呼吸期间监测、非COVID-19 ARDS激素及特定亚表型生物制剂。

适用人群与场景

  • ARDS患者,涵盖当前标准与演进标准所讨论的人群;原文未给出具体纳入/排除标准或场景限定。

诊断标准与关键阈值

  • 原文未提及具体的ARDS诊断标准、评分界值或启动/停止阈值。

处置流程与药物剂量

  • 当前标准通气管理:限制潮气量和气道压,并按标准方法设置PEEP。
  • 当前标准通气辅助:中重度ARDS采用俯卧位通气。
  • 当前标准通气辅助:严重低氧血症或通气困难患者,在俯卧位后考虑VV-ECLS。
  • 当前标准药物治疗:COVID-19相关ARDS使用皮质激素;非休克患者采用保守液体策略。
  • 演进标准可能包括:限制驱动压或机械功、个体化PEEP滴定、自主呼吸期间监测、非COVID-19 ARDS激素、针对特定亚表型的生物制剂。

红旗征与不能漏的情况

  • 原文未提及具体的红旗征或不能漏诊的情况。

研究设计与关键结果

  • 本文为叙述性综述,未报告原始研究的设计、样本量、效应量或统计学结果。

证据类型、等级与局限

  • 证据类型:叙述性综述;原文未给出证据等级或推荐强度;局限包括未系统检索、未提供具体数值阈值或剂量。

对床旁实践的改变

  • 当前标准可指导床旁实践:ARDS患者限制潮气量和气道压、标准PEEP设置;中重度ARDS俯卧位;严重低氧或通气困难者俯卧位后考虑VV-ECLS;COVID-19相关ARDS使用皮质激素;非休克患者保守液体策略。
  • 演进标准(驱动压/机械功限制、个体化PEEP、自主呼吸监测、非COVID激素、生物制剂)尚未成为广泛采用的常规标准,原文未给出具体实施阈值或剂量。

指南或共识出处

  • 原文未提及具体指南或共识名称;本文为Intensive Care Med发表的叙述性综述。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Care for patients with acute respiratory distress syndrome (ARDS) has changed considerably over the 50 years since its original description. Indeed, standards of care continue to evolve as does how this clinical entity is defined and how patients are grouped and treated in clinical practice. In this narrative review we discuss current standards - treatments that have a solid evidence base and are well established as targets for usual care - and also evolving standards - treatments that have promise and may become widely adopted in the future. We focus on three broad domains of ventilatory management, ventilation adjuncts, and pharmacotherapy. Current standards for ventilatory management include limitation of tidal volume and airway pressure and standard approaches to setting PEEP, while evolving standards might focus on limitation of driving pressure or mechanical power, individual titration of PEEP, and monitoring efforts during spontaneous breathing. Current standards in ventilation adjuncts include prone positioning in moderate-severe ARDS and veno-venous extracorporeal life support after prone positioning in patients with severe hypoxemia or who are difficult to ventilate. Pharmacotherapy current standards include corticosteroids for patients with ARDS due to COVID-19 and employing a conservative fluid strategy for patients not in shock; evolving standards may include steroids for ARDS not related to COVID-19, or specific biological agents being tested in appropriate sub-phenotypes of ARDS. While much progress has been made, certainly significant work remains to be done and we look forward to these future developments.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Menk M, Estenssoro E, Sahetya SK, et al. Current and evolving standards of care for patients with ARDS. Intensive Care Med. 2020. PMID: 33156382. doi:10.1007/s00134-020-06299-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。